Plano TX Cosmetic Dentist Implant Dentistry & Family Dental Services Announced

The leading Plano, Texas dental practice Millennium Dental, with appointments available at 972-491-2677, announced an expansion of the coveted general, cosmetic and restorative dentistry it is able to provide to help patients in the community maintain the most beautiful, healthy smile.

Plano, United States - September 13, 2017 /PressCable/ —

The award winning dental clinic Millennium Dental has announced an expansion of the popular general, cosmetic and reconstructive dentistry services it is able to provide patients in Plano, Texas, and its surrounding areas.

More information is available at https://www.millenniumdds.com/.

The Millennium Dental is the most popular and highest rated dental practice in Plano, Texas, for its extensive experience helping patients of all ages in the community enjoy a beautiful, healthy smile with its proven range of preventive, cosmetic and reconstructive dentistry at prices anyone can afford.

The dental practice has announced an expansion of the award winning dentistry it is able to provide, which includes all the routine cleanings, oral cancer screenings or periodontal treatments needed to help maintain peek oral health and the custom veneers, bridges, crowns, implants, dentures or teeth whitening to restore a white, functional smile patients can be confident about.

This industry leading range of general, cosmetic and reconstructive dentistry is delivered by a team of friendly dental assistants and hygienists led by board certified dentist Dr. Jana Harrison who are known for combining the most gentle, individualized approach to dental care with a warm, welcoming environment to ensure a comfortable experience for each and every patient. More information at https://www.millenniumdds.com/porcelain-veneers/

The Millennium Dental team explains that “our practice is committed to dental excellence and superior patient care. We want to help each and every one of our patients experience the comfort and confidence that comes with a beautiful, healthy smile and our top priority, from the moment they walk through the door, is their comfort and satisfaction. We invite everyone to come discover the difference we can make in their life and why we’re Plano’s choice for dentistry.”

Appointments and consultations with Millennium Dental or more information on the complete range of dental services it is able to provide can be requested at 972-491-2677 or through the website link provided above along with multiple patient testimonials and before & after smile galleries showcasing its unique dentistry skill and patient care philosophy or a virtual tour of its offices conveniently located at 7705 San Jacinto Place, Ste. 400, Plano, Texas.

Contact Info:
Name: Dr. Jana Harrison
Organization: Millennium Dental
Address: 7705 San Jacinto Pl #400, Plano, TX 75024, United States

For more information, please visit https://www.millenniumdds.com/

Source: PressCable

Release ID: 238628

More News From dailyxtreme.com

South Africa's governing ANC to announce party leader on Sunday

Dec 15, 2017

JOHANNESBURG (Reuters) - South Africa's ruling African National Congress (ANC) will announce current president Jacob Zuma's successor as party leader on Sunday as it looks to conclude a bruising leadership battle and focus on policy, a party spokesman told radio station 702 on Friday."On Sunday morning as we arrive we should be able to make an announcement of the top six and take nomination of the rest of the leadership. We need to take out this item from the conference agenda as quickly as possible," party spokesman Zizi Kodwa said.The ANC holds an election this weekend to replace Zuma as...

Pfizer's Xeljanz gets FDA nod as joint disease treatment

Dec 15, 2017

(Reuters) - U.S. drugmaker Pfizer Inc said on Thursday the U.S. Food and Drug Administration (FDA) approved two doses of its drug Xeljanz for treatment of a joint disease.Xeljanz was approved as a 5-mg dose taken twice daily and as an extended-release 11-mg dose taken once daily as a drug for patients with active psoriatic arthritis who have not responded to other treatments.Psoriatic arthritis, a form of arthritis that affects some people who have skin disease psoriasis, is characterized by symptoms such as joint pain, stiffness and swelling.Xeljanz, which earned Pfizer $348 million in the latest quarter, was first approved...

Cameroon's Anglophones flee to Nigeria as crackdown grows

Dec 15, 2017

IKOM, Nigeria (Reuters) - When soldiers burst into her village in southwest Cameroon last month with guns blazing, small farmer Eta Quinta, 32, raced into the forest with three of her children."I found a canoe and I used it to cross over with my kids, not knowing where my husband and my (other) two kids are," she told Reuters across the border in Nigeria, where thousands of English-speaking Cameroonians have fled in past weeks.What began last year as peaceful protests by Anglophone activists against perceived marginalisation by Cameroon's Francophone-dominated elite has become the gravest challenge yet to President Paul Biya,...

Perrigo lines up bid for Merck's consumer health unit: sources

Dec 15, 2017

By Pamela Barbaglia and Ludwig BurgerLONDON/FRANKFURT (Reuters) - Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.Perrigo is expected to face competition from Swiss food giant Nestle and the private equity owners of German drug firm Stada, which are also lining up non-binding offers for the maker of Seven Seas vitamins and Bion nutritional supplements, the sources said on Thursday.Merck's financial adviser JPMorgan wants to shortlist bidders for the business before the end of...

Teva Pharm to lay off a quarter of workforce, suspends dividend

Dec 15, 2017

By Tova Cohen and Ari RabinovitchTEL AVIV (Reuters) - Teva Pharmaceutical Industries is to cut its workforce by more than a quarter, give up many of its manufacturing plants and suspend its dividend on ordinary shares in a much-anticipated overhaul to help pay off its debts.The Israel-based company, the world's largest generic drugmaker, said on Thursday the move will result in a reduction of 14,000 jobs globally, with the majority to come in 2018.The two-year restructuring plan is intended to reduce Teva's cost base by $3 billion by the end of 2019, out of an estimated cost base for 2017...

Daily Extreme is created to share our experience on the amazing extreme outdoor activities in the world. We play it extreme, but safe.

Contact us: sales@dailyxtreme.com

Motorcycle Racing Skateboarding Skiing Snowboarding Surfing Wind Surfing Cycling Canoeing & Kayaking Press